E. Troost

发表

F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) – A prospective externally validated study

Philippe Lambin, Wouter van Elmpt, Cary Oberije, 2018 .

Prognostic Value of Head and Neck Tumor Proliferative Sphericity From 3’-Deoxy-3’-[18F] Fluorothymidine Positron Emission Tomography

M. Hatt, D. Visvikis, M. Majdoub, 2018, IEEE Transactions on Radiation and Plasma Medical Sciences.

Innovations in Radiotherapy Planning of Head and Neck Cancers: Role of PET

Johan Bussink, Otto C. Boerman, Johannes H.A.M. Kaanders, 2010, Journal of Nuclear Medicine.

Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours.

Johan Bussink, Johannes H A M Kaanders, W. Oyen, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Imaging-Based Treatment Adaptation in Radiation Oncology

W. Oyen, D. Thorwarth, E. Troost, 2015, The Journal of Nuclear Medicine.

18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome

B. Hoeben, W. Oyen, J. Bussink, 2013, The Journal of Nuclear Medicine.

Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.

W. Oyen, J. Bussink, J. Kaanders, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The role of interleukin-1 beta and other potential genetic markers as indicators of gastric cancer risk

E. El-Omar, W. Chow, E. Troost, 2016 .

Validation of PET imaging for non-invasive characterization of head and neck tumors.

E. Troost, 2010 .

Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines.

J. Bussink, J. Kaanders, A. J. van der Kogel, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

18F-FDG and 18F-FLT Do Not Discriminate Between Reactive and Metastatic Lymph Nodes in Oral Cancer

W. Oyen, J. Bussink, J. Kaanders, 2009, Journal of Nuclear Medicine.

Intratumoral Spatial Distribution of Hypoxia and Angiogenesis Assessed by 18F-FAZA and 125I-Gluco-RGD Autoradiography

W. Oyen, J. Bussink, J. Kaanders, 2008, Journal of Nuclear Medicine.

18F-FDG PET Early Response Evaluation of Locally Advanced Non–Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy

W. Oyen, J. Bussink, J. Kaanders, 2013, The Journal of Nuclear Medicine.

An evaluation of some ophthalmological instruments

E. Troost, F. Strik, J. Junge, 1977, Documenta Ophthalmologica.

18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors

W. Oyen, J. Bussink, J. Kaanders, 2010, Journal of Nuclear Medicine.

PET in the management of locally advanced and metastatic NSCLC

W. Oyen, E. Visser, J. Bussink, 2015, Nature Reviews Clinical Oncology.

The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk.

E. El-Omar, W. Chow, E. Troost, 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

PET of Hypoxia with 89Zr-Labeled cG250-F(ab′)2 in Head and Neck Tumors

B. Hoeben, W. Oyen, J. Bussink, 2010, Journal of Nuclear Medicine.

Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3′-fluoro-3′-deoxy-thymidine ([18F]FLT) PET imaging

W. Oyen, C. Figdor, A. Windhorst, 2011, Proceedings of the National Academy of Sciences.

3′-Deoxy-3′-18F-Fluorothymidine PET–Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients

W. Oyen, J. Grotenhuis, A. Heerschap, 2012, The Journal of Nuclear Medicine.

18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients

W. Oyen, J. Bussink, P. Slootweg, 2007, Journal of Nuclear Medicine.

Histopathologic Validation of 3′-Deoxy-3′-18F-Fluorothymidine PET in Squamous Cell Carcinoma of the Oral Cavity

W. Oyen, J. Bussink, P. Slootweg, 2010, Journal of Nuclear Medicine.

Histopathologic Validation of 39-Deoxy-39-18F- Fluorothymidine PET in Squamous Cell Carcinoma of the Oral Cavity

W. Oyen, J. Bussink, P. Slootweg, 2010 .

18F-FLT PET changes during radio - therapy combined with cetuximab in head and neck squamous cell carcinoma patients

B. Hoeben, W. Oyen, J. Bussink, 2014, Nuklearmedizin.

Correlation of [18F]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts

W. Oyen, J. Bussink, J. Kaanders, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Correlation of [18F]FMISO autoradiography and pimonidazole immunohistochemistry in human head and neck carcinoma xenografts

W. Oyen, J. Bussink, J. Kaanders, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer

Johan Bussink, Johannes H.A.M. Kaanders, Esther G.C. Troost, 2013, Acta oncologica.

"Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763).

J. Kaanders, E. Troost, D. Schinagl, 2009, International journal of radiation oncology, biology, physics.

Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients

L. de Geus-Oei, E. Visser, J. Bussink, 2015, Nuclear medicine communications.

Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome

Dimitris Visvikis, Mathieu Hatt, Vincent Grégoire, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Functional paralysis of horizontal gaze

B. Troost, E. Troost, 1979, Neurology.

Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps

Daniela Thorwarth, Markus Alber, Johannes H A M Kaanders, 2011, Physics in medicine and biology.

Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial.

Henk Huizenga, Johan Bussink, Aswin L Hoffmann, 2012, International journal of radiation oncology, biology, physics.

Simultaneous localisation and mapping for laparoscopic liver navigation : a comparative evaluation study

Sebastian Bodenstedt, Stefanie Speidel, Carina Riediger, 2021 .

Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images

Daniela Thorwarth, Daniel Zips, Markus Alber, 2013, Acta oncologica.

Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging

Daniela Thorwarth, Markus Alber, Johannes H A M Kaanders, 2012, Physics in medicine and biology.

Modeling patterns of anatomical deformations in prostate patients undergoing radiation therapy with an endorectal balloon

Benoit M. Macq, Christian Richter, Eliott Brion, 2017, Medical Imaging.

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.

E. Smit, P. Postmus, M. Hochstenbag, 2015, European journal of cancer.

Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients

L. de Geus-Oei, J. Bussink, P. Span, 2012, Radiation oncology.

107 Comparison of 18F-MISO autoradiography with immunohistochemistry after modification of hypoxia in human glioma and squamous cell xenografts

J. Bussink, J. Kaanders, M. Philippens, 2006 .

106 Characterization of human squamous cell head and neck carcinoma xenografts using 18F-FLT and 18F-MISO autoradiography and immunohistochemistry